superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2021-12-31
- Valid until
- 2022-03-31
- Published
- 2022-02-16
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 916,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Amgen total equity: 6,700,000,000 United States dollar", as of 2021-12-31 (until 2022-03-31). Claim clm_BF8A71350904, https://asof.is/claim/clm_BF8A71350904, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000010/0000318154-22-000010-index.htm.
APA
AsOf. (2021). Amgen total equity: 6,700,000,000 United States dollar (as of 2021-12-31 (until 2022-03-31)) [Record clm_BF8A71350904]. Retrieved November 8, 2026, from https://asof.is/claim/clm_BF8A71350904 (source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000010/0000318154-22-000010-index.htm)
BibTeX
@misc{asof_clm_BF8A71350904,
author = {AsOf},
title = {Amgen total equity: 6,700,000,000 United States dollar},
year = {2021},
howpublished = {\url{https://asof.is/claim/clm_BF8A71350904}},
note = {Claim clm\_BF8A71350904, as of 2021-12-31 (until 2022-03-31); source: https://www.sec.gov/Archives/edgar/data/318154/000031815422000010/0000318154-22-000010-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_BF8A71350904.md/v1/claims/clm_BF8A71350904submit a correction